CDA Technology is a
Game Changer.
ANPAC BIO'S CDA (CANCER DIFFERENTIATION ANALYSIS) IS A REVOLUTIONARY TECHNOLOGY
LEARN MORE
Results Speak.
20+

CANCER TYPES

70+

SCREENED OUT CASES

75%
TO
90%

ACCURACY RATE

~50K

CONFIRMED TESTS

Our CEO
Dr. Chris Yu
Co-Founder/Chief Executive Officer
Dr. Chris Yu attended medical school before changing his studies to Physics and earning his Ph.D. from Pennsylvania State University. He is a successful Fortune 500 business executive, innovative engineer, and pioneering inventor.
FULL BIO
Meet the People Who Are Changing the Game